FH535|cas 108409-83-2|DC Chemicals

Cas No.:	108409-83-2
Chemical Name:	N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide
Synonyms:	N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide;FH535;2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide;FH-535;FH 535(FH-535);2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide FH535;Tcf Inhibitor, FH535;β-Catenin;β-catenin and PPAR
SMILES:	O=S(C1=CC(Cl)=CC=C1Cl)(NC2=CC=C([N+]([O-])=O)C=C2C)=O
Formula:	C₁₃H₁₀N₂O₄Scl₂
M.Wt:	361.2005
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:	FH535 is an inhibitor of Wnt/β-catenin and PPAR, with anti-tumor activities.
In Vivo:	FH535 (25 mg/kg, i.p.) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice. FH535 also represses angiogenesis in pancreatic cancer xenografts[2].
In Vitro:	FH535 is an inhibitor of Wnt/β-catenin and PPAR. FH535 inhibits PPARγ and PPARδ transactivation in HCT116 cells. FH535 (15 μM) activities depend on functional PPARδ but does not require a cysteine residue in the PPAR ligand-binding domain. FH535 inhibits recruitment of the coactivators GRIP1 and β-catenin to PPARδ and PPARγ. FH535 shows toxic effects on 12 carcinoma cell lines expressing wnt/β-catenin pathway[1]. FH535 (20 μM) suppresses the β-catenin pathway in pancreatic cancer cells, and inhibits pancreatic cancer cell migration. Furthermore, FH535 (20, 40 μM) inhibits pancreatic cancer cell invasion and cell growth[2]. FH535 represses angiogenesis-related genes in pancreatic cancer cells[3].

Cat. No.	Product name	Field of application
DC10472	Toxoflavin (PKF118-310)	Toxoflavin (Xanthothricin) is a dual-function bioactive compound with multimodal therapeutic potential.
DC10888	SKL2001	SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity.
DC12384	LF3	LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 with an IC50 less than 2 μM.
DC9880	KYA1797K	KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
DC10556	KY1220	KY1220 is a compound that destabilizes both β-catenin and Ras, via targeting the Wnt/β-catenin pathway; with an IC50 of 2.1 μM in HEK293 reporter cells.
DC9952	IQ-1	IQ-1 has many functions such as decreasing Wnt-stimulated phosphorylation, maintaining the pluripotency of murine ESCs, preventing PP2A/Nkd interaction and so on.
DC10680	iCRT3	iCRT3 is an inhibitor of both Wnt and β-catenin-responsive transcription.
DC3130	ICG-001	ICG-001 is a small-molecule antagonist of b-catenin/TCF-mediated transcription (IC50 = 3 uM) and specifically downregulates the expression of a subset of b-catenin/TCF-responsive genes. ICG-001 binds specifically to cyclic AMP response element-binding pro
DC7414	FH535	FH535 is a compound that suppresses both Wnt/beta-catenin and peroxisome proliferator-activated receptor (PPAR) signaling.